Health Care: Drugs

Dynavax Technologies Corp (DVAX: NASDAQ)

$1.51 n/a | n/a%
10/21/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 11.25M 9.71M 21.61M 23.95M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 11.25M 9.71M 21.61M 23.95M
Selling, General, and Administrative Expenses 25.94M 28.16M 17.57M 16.88M
Research & Development 50.87M 49.15M 51.32M 53.68M
Operating Income before D & A (EBITDA) -65.56M -67.60M -47.28M -46.61M
Depreciation & Amortization 2.25M 2.50M 2.77M 2.76M
Interest Income 116.00K 291.00K 103.00K 85.00K
Other Income - Net -348.00K -293.00K 834.00K -8.15M
Special Income / Charges -926.00K 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -68.97M -70.10M -49.12M -57.44M
Interest Expense 0.00 2.35M 1.96M 1.65M
Pre-Tax Income -68.97M -72.45M -51.07M -59.09M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -66.72M -69.95M -48.60M -57.31M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -66.72M -69.95M -48.60M -57.31M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -66.72M -69.95M -48.60M -57.31M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-65.79M -69.95M -48.60M -57.31M
Preferred Dividends
Net Income Available To Common -75.19M -69.95M -48.60M -57.31M
Basic EPS from Continuing Ops. -0.38 -0.41 -0.39 -0.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.38 -0.41 -0.39 -0.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.38 -0.41 -0.39 -0.69
Basic Normalized Net Income/Share -0.38 -0.41 -0.39 -0.69
EPS fr Continuing Ops. -0.38 -0.41 -0.39 -0.69
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.38 -0.41 -0.39 -0.69
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.38 -0.41 -0.39 -0.69
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.38 -0.41 -0.39 -0.69
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DVAX

Latest DVAX Headlines from TheStreet

More Financial News for DVAX

Press Releases for DVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter